Ad is loading...
BIRDX vs MGLAX
BIRDX vs MGLAX Comparison
Open Charts BIRDX vs MGLAX
iShares Developed Real Estate Idx Instl
Price$7.99
Change-$0.01 (-0.12%)
VolumeN/A
Net Assets217.29M
MFS Global Real Estate A
Price$15.72
Change-$0.01 (-0.06%)
VolumeN/A
Net Assets2.21B
BIRDX vs MGLAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
VS
BIRDX vs. MGLAX commentary
Apr 26, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIRDX is a Buy and MGLAX is a Buy.
FUNDAMENTALS
Fundamentals
MGLAX has more cash in the bank: 2.21B vs. BIRDX (217M). BIRDX pays higher dividends than MGLAX: BIRDX (3.07) vs MGLAX (2.33). BIRDX was incepted earlier than MGLAX: BIRDX (10 years) vs MGLAX (16 years). MGLAX (1.20) is less costly to investors than BIRDX (0.20). MGLAX is a more actively managed with annual turnover of: 48.00 vs. BIRDX (3.00). MGLAX has a lower initial minimum investment than BIRDX: MGLAX (1000) vs BIRDX (2000000). MGLAX annual gain was more profitable for investors over the last year : 3.60 vs. BIRDX (-6.09). MGLAX return over 5 years is better than : 20.74 vs. BIRDX (15.39).
| BIRDX | MGLAX | BIRDX / MGLAX | |
| Total Expense Ratio | 0.20 | 1.19 | 17% |
| Annual Report Gross Expense Ratio | 0.20 | 1.20 | 17% |
| Fund Existence | 10 years | 16 years | - |
| Gain YTD | 1.807 | -1.688 | -107% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 2000000 | 1000 | 200,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 217M | 2.21B | 10% |
| Annual Yield % from dividends | 3.07 | 2.33 | 132% |
| Returns for 1 year | -6.09 | 3.60 | -169% |
| Returns for 3 years | -22.35 | -20.20 | 111% |
| Returns for 5 years | 15.39 | 20.74 | 74% |
| Returns for 10 years | N/A | 17.03 | - |
View a ticker or compare two or three
VS
VS
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JNGLX | 66.67 | 0.11 | +0.17% |
| Janus Henderson Global Life Sciences D | |||
| GTDDX | 33.38 | N/A | N/A |
| Invesco EQV Emerging Markets All Cap A | |||
| GSVPX | 14.92 | N/A | N/A |
| Goldman Sachs Small/Mid Cap Value P | |||
| WMIDX | 10.95 | N/A | N/A |
| WCM Mid Cap Quality Value Investor | |||
| VVIEX | 11.76 | N/A | N/A |
| VOYA VACS Index Series EM Portfolio | |||